Ann Lee-Karlon Founder of EpiBiologics Backed byPolaris PartnersVivo CapitalFrank KungJon Flint LinkedIn SourcesEpiBiologics Closes 07M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology — 2026-01 Browse all founders · Browse investors
